Latest in Ozempic lowers Alzheimer’s risk: Research
Sort by
189 items
-
Business - CNBC
Mattel, Hasbro lower guidance ahead of holiday season
Toy giants Mattel and Hasbro decreased 2024 guidance prior to the holiday season as toy sales continue to fall during the third quarter.9 hours ago -
Top stories - NBC News
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal ...16 hours ago -
Business - CNBC
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.16 hours ago -
Tech - Wired
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical ...Yesterday -
Health - ABC News
UK regulator approves second Alzheimer's drug in months but government won't pay for it
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost ...Yesterday - United Kingdom -
Politics - The Hill
Ozempic lowers Alzheimer’s risk: Research
The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer's disease among people with Type 2 diabetes, according to a new study published Thursday. Alzheimer’s disease is the ...8 hours ago -
Politics - The Hill
Drugmaker wants an end to Ozempic copies
Presented by Alliance for Aging Research — Plus: FDA recalls thousands of antidepressant bottles due to cancer-causing chemical {beacon} Health Care Health Care The Big Story Novo Nordisk wants ...Yesterday -
Politics - The Hill
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...Yesterday -
Business - The Wall Street Journal
Michelin Lowers Guidance After Sales Fall
The market downturn in Europe was caused by customers’ weaker purchasing power due to high interest rates and uncertainties over the pace of the transition to electric vehicles, Michelin said.Yesterday -
Business - CNBC
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.Yesterday -
World - ABC News
UK regulator approves second Alzheimer's drug in months but government won't pay for it
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost ...Yesterday - United Kingdom -
Top stories - BBC News
NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the watchdog says.Yesterday -
Science - The New York Times
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.Yesterday -
Business - The Wall Street Journal
Air Liquide Revenue Hit by Lower Energy Prices
Air Liquide reported a drop in revenue for the third quarter and missed analysts’ expectations due to lower energy prices and negative currency effects.Yesterday -
Top stories - BBC News
Why Kompany managing Bayern is 'not a risk'
Nedum Onuoha discusses how his former Manchester City team-mate Vincent Kompany will lead Bayern Munich in this season's Champions League.Yesterday -
World - Financial Times
Policymakers should not exacerbate the risks of deglobalisation
A fragmented approach to rulemaking in banking around the world has the potential to be destructiveYesterday -
Top stories - NBC News
Biden delivers remarks on lowering prescription drug costs
Watch live coverage as President Biden travels to New Hampshire to deliver remarks on his administration's efforts to lower the cost of prescription drugs.2 days ago - Joe Biden -
Business - The New York Times
Arkansas May Have Vast Lithium Reserves, Researchers Say
Federal and state researchers said there might be five million to 19 million tons of lithium, more than enough to meet the world’s demand for the battery ingredient.3 days ago -
Tech - ABC News
Slack researcher discusses the fear, loathing and excitement surrounding AI in the workplace
Artificial intelligence’s recent rise to the forefront of business has left most office workers wondering how often they should be using the technology and worried about whether a computer will ...3 days ago -
Top stories - CBS News
Tasmanian tiger de-extinction research advances
Colossal Biosciences says it's made a breakthrough toward the de-extinction of the thylacine, or Tasmanian tiger.4 days ago - Golf -
Health - The New York Times
Sammy Basso, Advocate for Progeria Research, Is Dead at 28
One of about 150 people known to have a rare condition that causes rapid aging, he sought to raise awareness and participated in the search for a cure.4 days ago -
Top stories - The New York Times
There Is No Leadership Without Risk
Those in positions of leadership fear they will say the wrong thing, or say what they believe to be the right thing in the wrong way.4 days ago -
Business - The New York Times
Money Market Rates Are Lower, Yes. But Compared to What?
Even with further Fed rate cuts likely, money market funds are a good alternative for stashing cash, and investors are still flocking to them, our columnist says.6 days ago -
World - Financial Times
Cancer Research chief urges ministers to speed up UK tobacco bill
Further delay would cast doubt on commitment to shift NHS to a more preventive health system, says Michelle Mitchell6 days ago - United Kingdom -
World - The Guardian
US congress research warns of risk of cost blowouts for Australia in Aukus submarine program
Report also cast doubt on whether any rigorous cost-benefit analysis was done before the 2021 announcement. Follow our Australia news live blog for latest updates Get our breaking news email ...October 18 - Australia -
Politics - The Hill
Weight loss drugs may help reduce drug and alcohol misuse: Research
Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found ...October 17 -
Business - Financial Times
ECB lowers rates to 3.25% as inflation slows
Christine Lagarde says Eurozone’s central bankers are close to ‘breaking the neck’ of soaring price pressuresOctober 17 -
Top stories - CBS News
Study finds drugs like Ozempic could help with substance addiction
New research suggests diabetes drugs like Ozempic, which some people also take to lose weight, may also help patients suffering from substance addiction. CBS News contributor Dr. Celene Gounder has ...October 17 -
Top stories - BBC News
What Lower Inflation Means For You
There’s been a surprise fall in the rate at which prices increaseOctober 16 - Inflation -
Top stories - BBC News
New skin research could help slow signs of ageing
The research could also be used to produce artificial skin for transplantation and prevent scarring.October 16 -
-
-
Top stories - CBS News
New research suggests undiagnosed ADHD may be more common in U.S. adults
A new survey reveals that 25% of U.S. adults suspect they have undiagnosed ADHD, but only 13% have discussed it with a doctor. CBS News medical contributor Dr. Céline Gounder explains the ...October 15 -
World - Financial Times
The inflation risk for emerging markets
Fiscal indiscipline looms as the biggest threat after central bank battles to slow rising pricesOctober 15 -
Business - Inc.
New Global Research Suggests It May Be Time to Retire ‘Hard’ and ‘Soft’ Skills
To boost chances for long term growth, companies need to reconsider their skills development system.October 15 -
World - ABC News
Nobel economics prize is awarded for research into why countries succeed or fail
The Nobel memorial prize in economics has been awarded to three U.S.-based academics for research into why societies with poor rule of law and exploitative institutions do not generate sustainable ...October 14 -
Top stories - NBC News
Nobel economics prize goes to global inequality researchers
Three U.S.-based academics won the 2024 Nobel economics prize for their research into why global inequality persists.October 14